Aluminum Adjuvant -- Bad JuJu / and Interactions.

[Guest guest]

Randi has been on our email list - not real active at present

I don't have the URL for this whole article

(first part from an earlier article - source at the end.

Written by Roman Bystrianyk

Monday, 21 September 2009 22:17

Randi Allaire was an Information Management

Specialist in the military for almost four years.

Three and one-half years were spent with the Air

National Guard as Information Management, the

previous five and half was with the Army Guard as

a Flight Operations Specialist.

As part of the military's program to protect

their troops from chemical and biological

weapons, Randi was required to take the anthrax

vaccine. On March 14, 1999 she was given her

fourth anthrax vaccine. It was after that shot

that she has suffered chronic fatigue, memory

lapses, migraines, pain in the forearms, and

other aches and pains. She received no help with

her condition and only denials that the anthrax

vaccine could cause any of these problems and

that the cause of her problems was likely the

" flu " or too much " stress " . She was eventually

thrown out of the military because she refused to

take the fifth anthrax vaccine shot in fear for her own personal health.

Aluminum is the most commonly licensed adjuvant

that is added to a large number of vaccines. An

adjuvant is a substance added to a vaccine to

amplify the immune response. Aluminum compounds,

which were identified over 90 years ago as

adjuvants, are considered by the pharmaceutical

industry and various government agencies as safe.

The FDA (Food and Drug Administration) has

continued to approve the use of aluminum as an

additive to vaccines for many years.

Despite these assurances that aluminum and all

vaccine ingredients are safe, large numbers of

military veterans who suffer from Gulf War

Syndrome as well as parents of children who

suffer from various neurologic conditions

including Autism strongly believe that the

vaccines were often at least in part a cause of their health problems.

A recent study in the Journal of Inorganic

Biochemistry examined the possible neurotoxicity

of aluminum. This new work builds on a previous

study where the researchers had injected mice

with a combination of aluminum and squalene,

another vaccine adjuvant which is not licensed in North America.

In that study the investigators injected mice

with adjuvants that mimicked the anthrax vaccine

schedule set by the Anthrax Vaccine Immunization

Program. The investigators concluded in that

study " our data suggest that the aluminum

hydroxide adjuvant induces both behavioral and

motor deficits and the loss of motor neurons and

increased presence of astrocytes [astrocytes are

cells that express inflammatory markers] in

spinal cord and neuronal apoptosis [cell death]

in the primary motor cortex. " When Professor Shaw

was asked in an article by Pieta Wooley about

this research Professor Shaw replied " No one in

my lab wants to get vaccinated. This totally

creeped us out. We weren't out there to poke

holes in vaccines. But all of a sudden, oh my God-we've got neuron death! "

In this new study (also termed experiment 2),

mice received 6 aluminum hydroxide injections

over a 2 week period. These mice along with

control mice were subjected to a more rigorous

behavioral testing regime than the original experiment.

The investigators found " the multiple aluminum

hydroxide injections of experiment 2 showed

profound effects on motor and other behaviours..

.. Multiple aluminum injections produced

significant behavioural outcomes including

changes in locomotion behavior, and induced

memory deficits on water maze tasks. "

I asked Professor Shaw " To your knowledge have

there been any autopsies performed on service men

and women that had GWS [Gulf War Syndrome] and

have died to examine if they have a similar

pattern of aluminum contamination that you

discovered in your research? " He responded " that

it has not been done to my knowledge. " I also

asked " Has there been an examination of people

with autism to examine the obvious likely link

between aluminum and mercury contamination and

that condition? " Again he responded " Not to my knowledge. "

It is important to note that while this and their

previous study showed " significant behavioural

and neuropathological outcomes with aluminum

hydroxide " that these results were achieved under

minimal conditions and that the effect of

multiple other factors in real situation such as

" stress, multiple vaccinations, and exposure to

other toxins " would more than likely make the

outcomes worse. " A recent study examining some of

these factors in combination showed that stress,

vaccination, and pyridostigmine bromide

(Pyridostigmine bromide has been FDA approved for

military use during combat situations as an agent

to be given prior to exposure to the nerve agent

Soman in order to increase survival), may

synergistically act on multiple stress-activated

kinases in the brain to induce neurologic impairment in GWS. "

I asked Professor Shaw, " In your opinion why do

various governmental agencies continue to insist

that vaccines are safe when you clearly state in

your research paper that ‘it also seems that

there have been no rigorous animal studies of

potential aluminum adjuvant toxicity. The absence

of such studies is peculiar given the well known

observation that aluminum in general can be

neurotoxic under a number of conditions and

adjuvants in particular have previously been

implicated in neurological disease'? " Professor

Shaw replied " A less charitable person than I

would likely look at links between pharma and the

regulatory agencies. I don't know of any safe

adjuvants. Aluminum is the one considered ‘safe'. "

The authors conclude, " Overall, the results

reported here mirror previous work that has

clearly demonstrated that aluminum, in both oral

and injected forms, can be neurotoxic. " I

followed up with Professor Shaw " knowing what you

know about aluminum from your research would you

personally use a vaccine that contains aluminum? "

He responded " No, and I don't. "

The following vaccines (vaccine name/trade name,

manufacturer, and information from the product

insert) contain aluminum adjuvant:

Anthrax Vaccine Adsorbed/Biothrax, Emergent

BioDefense Operations Lansing, Inc., " The final

product is formulated to contain 1.2 mg/mL

aluminum, added as aluminum hydroxide in 0.85% sodium chloride. "

Diphtheria & Tetanus Toxoids Adsorbed, Sanofi

Pasteur Inc, " Each 0.5 mL dose is formulated to

contain 6.7 Lf of diphtheria toxoid, 5 Lf of

tetanus toxoid, and not more than 0.17 mg of aluminum. "

Diphtheria & Tetanus Toxoids & Acellular

Pertussis Vaccine Adsorbed/Tripedia, Sanofi

Pasteur, Inc., " Each 0.5 mL dose also contains,

by assay, not more than 0.170 mg of aluminum and

not more than 100 μg (0.02%) of residual formaldehyde. "

Diphtheria & Tetanus Toxoids & Acellular

Pertussis Vaccine Adsorbed/Infanrix,

GlaxoKline Biologicals, " Each 0.5-mL dose

contains 4.5 mg of NaCl and aluminum adjuvant

(not more than 0.625 mg aluminum by assay). Each

dose also contains ≤100 mcg of residual

formaldehyde and ≤100 mcg of polysorbate 80 (Tween 80). "

Diphtheria & Tetanus Toxoids & Acellular

Pertussis Vaccine Adsorbed/DAPTACEL, Sanofi

Pasteur, Ltd., " Other ingredients per 0.5 mL dose

include 1.5 mg aluminum phosphate (0.33 mg of

aluminum) as the adjuvant, ≤5 μg residual

formaldehyde, <50 ng residual glutaraldehyde and

3.3 mg (0.6% v/v) 2-phenoxyethanol (not as a preservative) . "

Diphtheria and Tetanus Toxoids and Acellular

Pertussis Adsorbed, Hepatitis B (Recombinant) and

Inactivated Poliovirus Vaccine Combined/Pediarix,

GlaxoKline Biologicals, " Each 0.5-mL dose

also contains 4.5 mg of NaCl and aluminum

adjuvant (not more than 0.85 mg aluminum by

assay). Each dose also contains ≤100 mcg of

residual formaldehyde and ≤100 mcg of polysorbate 80 (Tween 80). "

Diphtheria and Tetanus Toxoids and Acellular

Pertussis Adsorbed and Inactivated Poliovirus

Vaccine/Kinrix, GlaxoKline Biologicals,

" Each 0.5-mL dose contains 4.5 mg of NaCl and

aluminum adjuvant (not more than 210 0.6 mg

aluminum by assay). Each dose also contains

≤100 mcg of residual formaldehyde and 211

≤100 mcg of polysorbate 80 (Tween 80). "

Diphtheria and Tetanus Toxoids and Acellular

Pertussis Adsorbed, Inactivated Poliovirus and

Haemophilus b Conjugate (Tetanus Toxoid

Conjugate) Vaccine/Pentacel, Sanofi Pasteur, Ltd,

" Other ingredients per 0.5 mL dose include 1.5 mg

aluminum phosphate (0.33 mg aluminum) as the

adjuvant, polysorbate 80 (approximately 10 ppm by

calculation) , ≤5 μg residual formaldehyde,

<50 ng residual glutaraldehyde, ≤50 ng residual

bovine serum albumin, 3.3 mg (0.6% v/v)

2-phenoxyethanol (not as a preservative) and <4

pg of neomycin and <4 pg polymyxin B sulfate. "

Haemophilus b Conjugate (Meningococcal Protein

Conjugate) and Hepatitis B (Recombinant)

Vaccine/Comvax, Merck & Co, Inc, " The individual

PRP-OMPC and HBsAg adjuvanted bulks are combined

to produce COMVAX. Each 0.5 mL dose of COMVAX is

formulated to contain 7.5 mcg PRP conjugated to

approximately 125 mcg OMPC, 5 mcg HBsAg,

approximately 225 mcg aluminum as amorphous

aluminum hydroxyphosphate sulfate, and 35 mcg

sodium borate (decahydrate) as a pH stabilizer,

in 0.9% sodium chloride. The vaccine contains not

more than 0.0004% (w/v) residual formaldehyde. "

Hepatitis A Vaccine, Inactivated/ Havrix,

GlaxoKline Biologicals, " Each 1-mL adult

dose of vaccine consists of 1440 EL.U. of viral

antigen, adsorbed on 0.5 mg of aluminum as

aluminum hydroxide. Each 0.5-mL pediatric dose of

vaccine consists of 720 EL.U. of viral antigen,

adsorbed onto 0.25 mg of aluminum as aluminum hydroxide. "

Hepatitis A Vaccine, Inactivated/ VAQTA, Merck &

Co, Inc, " Pediatric/Adolesce nt Formulation (12

Months Through 18 Years of Age): each 0.5 mL dose

contains approximately 25U of hepatitis A virus

antigen adsorbed onto approximately 0.225 mg of

aluminum provided as amorphous aluminum

hydroxyphosphate sulfate, and 35 mcg of sodium

borate as a pH stabilizer, in 0.9% sodium

chloride. Adult Formulation (19 Years of Age and

Older): each 1 mL dose contains approximately 50U

of hepatitis A virus antigen adsorbed onto

approximately 0.45 mg of aluminum provided as

amorphous aluminum hydroxyphosphate sulfate, and

70 mcg of sodium borate as a pH stabilizer, in 0.9% sodium chloride. "

Hepatitis A Inactivated & Hepatitis B

(Recombinant) Vaccine/Twinrix, GlaxoKline

Biologicals, " A 1.0-mL dose of vaccine contains

720 ELISA Units of inactivated hepatitis A virus

and 20 mcg of recombinant HBsAg protein. One dose

of vaccine also contains 0.45 mg of aluminum in

the form of aluminum phosphate and aluminum

hydroxide as adjuvants, amino acids, 5.0 mg

2-phenoxyethanol as a preservative, sodium

chloride, phosphate buffer, polysorbate 20, Water

for Injection, traces of formalin (not more than

0.1 mg), a trace amount of thimerosal (<1 mcg

mercury) from the manufacturing process, and

residual MRC-5 cellular proteins (not more than 2.5 mcg). "

Hepatitis B Vaccine (Recombinant) /Engerix- B,

GlaxoKline Biologicals, " Pediatric/Adolesce

nt: Each 0.5-mL dose contains 10 mcg of hepatitis

B surface antigen adsorbed on 0.25 mg aluminum as

aluminum hydroxide. The pediatric formulation

contains sodium chloride (9 mg/mL) and phosphate

buffers (disodium phosphate dihydrate, 0.98

mg/mL; sodium dihydrogen phosphate dihydrate,

0.71 mg/mL). Adult: Each 1-mL adult dose contains

20 mcg of hepatitis B surface antigen adsorbed on

0.5 mg aluminum as aluminum hydroxide. The adult

formulation contains sodium chloride (9 mg/mL)

and phosphate buffers (disodium phosphate

dihydrate, 0.98 mg/mL; sodium dihydrogen phosphate dihydrate, 0.71 mg/mL). "

Hepatitis B Vaccine (Recombinant) /Recombivax HB,

Merck & Co, Inc, " All formulations contain

approximately 0.5 mg of aluminum (provided as

amorphous aluminum hydroxyphosphate sulfate,

previously referred to as aluminum hydroxide) per

mL of vaccine. In each formulation, hepatitis B

surface antigen is adsorbed onto approximately

0.5 mg of aluminum (provided as amorphous

aluminum hydroxyphosphate sulfate) per mL of vaccine. "

Human Papillomavirus Quadrivalent (Types 6, 11,

16, 18) Vaccine, Recombinant/ Gardasil, Merck &

Co, Inc, " Each 0.5-mL dose of the vaccine

contains approximately 225 mcg of aluminum (as

Amorphous Aluminum Hydroxyphosphate Sulfate

adjuvant), 9.56 mg of sodium chloride, 0.78 mg of

L-histidine, 50 mcg of polysorbate 80, 35 mcg of

sodium borate, < 7 mcg yeast protein/dose, and

water for injection. The product does not contain

a preservative or antibiotics. "

Japanese Encephalitis Vaccine, Inactivated,

Adsorbed (Military & Commercial)/ Ixiaro, Merck &

Co, Inc, " Each dose of vaccine contains

approximately 6 mcg of purified, inactivated JEV

proteins and 250 mcg of aluminum hydroxide. "

Pneumococcal 7-valent Conjugate Vaccine

(Diphtheria CRM197 Protein)/Prevnar, Wyeth

Pharmaceuticals, Inc, " Each 0.5 mL dose is

formulated to contain: 2 μg of each saccharide

for serotypes 4, 9V, 14, 18C, 19F, and 23F, and 4

μg of serotype 6B per dose (16 μg total

saccharide); approximately 20 μg of CRM197

carrier protein; and 0.125 mg of aluminum per 0.5

mL dose as aluminum phosphate adjuvant. "

Tetanus & Diphtheria Toxoids, Adsorbed for Adult

Use, Massachusetts Public Health Biologic Lab,

" Each 0.5 ml dose contains by calculation not

more than 0.45 mg aluminum and less than 100 μg

(0.02%) of residual formaldehyde. The aluminum

phosphate functions as an adjuvant to increase

the immunogenicity of the toxoids in primary immunization. "

Tetanus & Diphtheria Toxoids Adsorbed for Adult

Use/DECAVAC, Sanofi Pasteur, Inc, " Each 0.5 mL

dose also contains a trace amount of thimerosal

[mercury derivative, (≤0.3 μg mercury/dose)

not as a preservative] from the manufacturing

process, aluminum adjuvant (not more than 0.28 mg

aluminum by assay), and not more than 100 μg

(0.02%) of residual formaldehyde. "

Tetanus Toxoid Adsorbed, Sanofi Pasteur, Inc,

" Each 0.5 mL dose is formulated to contain 5 Lf

(flocculation units) of tetanus toxoid and not

more than 0.25 mg of aluminum. The residual

formaldehyde content, by assay, is less than 0.02%. "

Tetanus Toxoid, Reduced Diphtheria Toxoid and

Acellular Pertussis Vaccine, Adsorbed/Adacel,

Sanofi Pasteur, Ltd, " Other ingredients per dose

include 1.5 mg aluminum phosphate (0.33 mg

aluminum) as the 15 adjuvant, ≤5 μg residual

formaldehyde, <50 ng residual glutaraldehyde and

3.3 mg (0.6% v/v) 16 2-phenoxyethanol (not as a preservative) . "

Tetanus Toxoid, Reduced Diphtheria Toxoid and

Acellular Pertussis Vaccine, Adsorbed/ Boostrix,

GlaxoKline Biologicals, " Each 0.5-mL dose

also contains 4.5 mg of NaCl, aluminum adjuvant

(not more than 0.39 mg aluminum by assay), ≤100

mcg of residual formaldehyde, and ≤100 mcg of polysorbate 80 (Tween 80). "

----------

Source:

Aluminum hydroxide injections lead to motor

deficits and motor neuron degeneration,

A. Shaw, et al, Journal of Inorganic

Biochemistry, 2009 Aug 20. [Epub ahead of print]

Aluminum adjuvant linked to Gulf War illness

induces motor neuron death in mice, M.S. Petrik,

et al, Neuromolecular Medicine, 2007, Vol. 1, No. 9, pp. 83-100

Conversation with Professor Shaw.

Shaw is Professor of Neurology and

Neurogenetics at the Institute of Psychiatry,

King's College London. He is also an Honorary

Consultant Neurologist at King's College Hospital

and Neurogeneticist at Guy's and St ' Hospitals.

An Interview with Staff Sergeant Randi Allaire in

the Air Force National Guard available at

<http://www.healthsentinel.com/joomla/index.php?option=com_content & view=article & \

id=2447:an-interview-with-staff-sergeant-randi-allaire-in-the-air-force-national\

-guard & catid=39:reports & Itemid=52>http://www.healthsentinel.com/

joomla/index. php?option=

com_content & view=article & id=2447:an-intervie

w-with-staff- sergeant- randi-allaire-

in-the-air- force-national- guard & catid=39:reports & Itemid=52

Vaccines Licensed for Immunization and

Distribution in the US with Supporting Documents,

<http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm093830.h\

tm>http://www.fda.

gov/BiologicsBlo odVaccines/ Vaccines/ ApprovedProducts /ucm093830. htm

Sheri Nakken, R.N., MA, Hahnemannian Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines -

http://www.nccn.net/~wwithin/vaccine.htm or

http://www.wellwithin1.com/vaccine.htm

Vaccine Dangers, Childhood Disease Classes &

Homeopathy Online/email courses - next classes start September 30 & October 1

http://www.wellwithin1.com/vaccineclass.htm or

http://www.wellwithin1.com/homeo.htm